Match each mood stabilizer commonly used in the management of bipolar disorder with its most characteristic adverse effect profile.
- LithiumHypothyroidism, fine tremor, and nephrogenic diabetes insipidus
- ValproateHepatotoxicity, pancreatitis, and neural tube defects
- LamotrigineBenign maculopapular rash and Stevens-Johnson syndrome
- CarbamazepineHyponatremia, agranulocytosis, and aplastic anemia
Cevap
Lithium matches with Hypothyroidism/tremor/NDI; Valproate matches with Hepatotoxicity/pancreatitis/neural tube defects; Lamotrigine matches with Rash/Stevens-Johnson syndrome; Carbamazepine matches with Hyponatremia/agranulocytosis/aplastic anemia.
Matching mood stabilizers to their adverse effects requires recognizing classic, high-yield toxicity profiles. Lithium is notorious for thyroid and renal effects (hypothyroidism, nephrogenic diabetes insipidus). Valproate classically causes hepatotoxicity, pancreatitis, and neural tube defects. Lamotrigine is most feared for severe skin reactions like Stevens-Johnson syndrome. Carbamazepine is distinguished by its risk of blood dyscrasias (agranulocytosis) and hyponatremia from SIADH.
Adım Adım Çözüm
Anahtar Kavram
Adverse effect profiles and toxicity signs of primary mood stabilizers